The management of Pharma Medical Affairs needs to learn from other inclusive companies about ethics, fair treatment, non-discriminatory policy, and other related issues. They are losing talent. More than 40 % of medical and health care workers in US are foreign graduates, many of them outstanding. This % is nowhere to be found at Roche pharma, and most of pharma in US anyway. The managment of pharma at Roche treats other nationalities with arrogance and discrimination, without looking closely to the talent they lock out.
Stability! Determine why there was such high turn-over in management (two different RBMs, two different RDs and three different VP of S&M) within 2.5 years, and find solutions. As the people on the front lines, it is extremely difficult to achieve goals which are constantly changing.
Provide more flexible working options, especially for people who are interacting with offshore teams.